Clin2
NCT06817421Possibly a fitRecruiting

Pneumococcal vaccine for children with severe malnutrition

Severe Acute Malnutrition in ChildhoodPneumococcal DiseasePneumococcal VaccinesPneumococcal InfectionPneumonia in Children

Part of Infections, Lungs & breathing clinical trials.

This study tests whether giving the pneumococcal vaccine during hospitalization for severe malnutrition can help prevent infections. It may help protect your child from serious illness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
214 people
Ages
6 months to 4.9 years
Study type
Interventional

Who can take part

  • Your child must be between 6 months and 5 years old.
  • Your child must be in the hospital for severe acute malnutrition (very low weight, small arm size, or swelling in feet/legs).
  • Your child must not have a known severe allergy to any vaccine component.
  • Your child must not have taken part in another clinical trial in the last 30 days.
  • You must be willing to give informed consent and follow study procedures.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06608199Recruiting· Phase 3
Pneumonia vaccine study for healthy infants

This study tests a new pneumonia vaccine (PCV13) in healthy infants to see if it works as well as a current vaccine. It compares the immune response and safety of the two vaccines.

Denpasar, Bali
NCT07629440Recruiting· Phase 3
New Pneumococcal Vaccine Study for Infants

This study tests a new vaccine to protect infants from pneumococcal disease (a serious bacterial infection). Researchers want to see how well the vaccine works and how safe it is in healthy babies aged 2–6 months.

Bessemer, Alabama
NCT07573462Recruiting· Phase 3
Safety study of a new pneumococcal vaccine for infants

This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.

Estero, Florida
NCT07660198Recruiting· Phase 3
Pneumonia vaccine catch-up study for kids and teens

This trial tests a catch-up pneumococcal vaccine for children and adolescents who may have missed some doses. It aims to see how safe and effective the vaccine is in healthy kids aged 15 months to 17 years.

Birmingham, Alabama
NCT06044077Recruiting· Phase 3
Testing a new pneumonia vaccine in healthy people

This trial tests a new 23-valent pneumococcal vaccine to see if it safely protects healthy people against pneumonia and other infections caused by pneumococcal bacteria.

Chengdu, Sichuan
NCT07399717Not yet recruiting
Probiotics for children hospitalized with pneumonia

This trial tests whether giving probiotics (beneficial bacteria) helps children aged 6 to 36 months recover from pneumonia while they are in the hospital. The study aims to see if adding probiotics to standard treatment improves outcomes.

Phú Thọ

Hear when a new Severe Acute Malnutrition in Childhood trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.